Response of Brain and Meningeal Metastases to Trastuzumab-Deruxtecan in a Patient with HER2-Low Breast Cancer: A Case Report.
Case Rep Oncol
; 16(1): 1425-1435, 2023.
Article
in En
| MEDLINE
| ID: mdl-38028580
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Case Rep Oncol
Year:
2023
Document type:
Article
Affiliation country:
Suiza